Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Unmet needs in rheumatoid arthritis treatment could be addressed by first-in-class pipeline

August 19, 2016

RA remains an incurable condition with no therapeutics that directly act to restore bone conten ...

R and D | Orthopaedics

Osteoporosis romosozumab

February 13, 2014

Osteoporosis occurs when the rate at which new bone is being made is slower than the rate at wh ...

Regulatory | R and D | Orthopaedics

Gout pegloticase

January 24, 2013

Drugs such as allopurinol and probenecid can be used to reduce uric acid levels, but do not wor ...

Regulatory | R and D | Orthopaedics

Amgen and Astellas agree alliance in Japan

May 29, 2013

Will focus on co-development of five Amgen medicines in Japan

North America | R and D | Biotechnology | Asia | Cardiology | Orthopaedics

Japanese regulator approves osteoporosis jelly

August 16, 2012

Teijin Pharma plans to launch first oral jelly for osteoporosis later this year

Asia | Orthopaedics

Fujifilm Kyowa Kirin Biologics starts operations

March 29, 2012

The jv between Fujifilm and Kyowa Hakko Kirin will develop, manufacture and sell biosimilars

Biotechnology | Finance | Asia | Orthopaedics

OctoPlus signs agreement with pharma company to develop controlled release formulation

January 11, 2012

Of a therapeutic compound for local delivery into joints

Europe | Drug Delivery | R and D | Orthopaedics

Stellar to acquire Tribute Pharmaceuticals

December 2, 2011

Tribute founder Rob Harris to lead merged firm

North America | Finance | Gastrointestinal | Orthopaedics

In Brief